Back to Results
First PageMeta Content
Vision / Vascular endothelial growth factor / Choroidal neovascularization / Macular degeneration / Glaucoma / Retina / Cell therapy / Angiogenesis / Aflibercept / Biology / Medicine / Angiology


Neurotech Announces FDA Acceptance of Investigational New Drug Application and Clinical Trial Initiation of Novel Therapy for Wet AMD Efficacy and Safety of Long-term, Continuous Anti-VEGF will be Assessed in Phase 2 Stu
Add to Reading List

Document Date: 2015-03-30 15:27:53


Open Document

File Size: 426,18 KB

Share Result on Facebook
UPDATE